Nicole Sandford
CIK 1849521 · Chief Executive Officer · last filed 2024-10-28
Nicole Sandford is a Chief Executive Officer who has filed 31 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for AWH, was dated Oct 28, 2024. Across all open-market trades the lifetime net is +$164.7K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
31
$164.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Aspira Women's Health Inc. (AWH) Delisted | Chief Executive Officer | 83,668 | $0.08 | $6.9K | $164.7K | 31 | 2024-10-28 |
Recent Filings
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-10-28 | Aspira Women's Health Inc. (AWH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-07-09 | Aspira Women's Health Inc. (AWH) Delisted | Grant (A) | +13,072 | $0 | EDGAR |
| 2024-06-03 | Aspira Women's Health Inc. (AWH) Delisted | Buy (P) | +9,493 | $23.0K | EDGAR |
| 2024-05-14 | Aspira Women's Health Inc. (AWH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-20 | Aspira Women's Health Inc. (AWH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-01-30 | Aspira Women's Health Inc. (AWH) Delisted | Buy (P) | +2,400 | $0 | EDGAR |
| 2023-12-06 | Aspira Women's Health Inc. (AWH) Delisted | Buy (P) | +5,000 | $16.8K | EDGAR |
| 2023-11-20 | Aspira Women's Health Inc. (AWH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-09-29 | Aspira Women's Health Inc. (AWH) Delisted | Grant (A) | +26,467 | $0 | EDGAR |
| 2023-09-29 | Aspira Women's Health Inc. (AWH) Delisted | Grant (A) | — | $0 | EDGAR |